BuzzSparks.org

Eiger BioPharmaceuticals


Hepatitis treatments

Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.

Homepage:
Total money raised: $12.4M

San Carlos
USA CA
Past
Wenjin Yang VP, Chemistry

May, 2013

Eiger BioPharmaceuticals raised $5.3M in a Series A round

SEC    sec.gov

February, 2009

Eiger BioPharmaceuticals raised $7.1M in a Series A round from InterWest Partners and Vivo Ventures

Eiger snaps up $7.1M to treat hepatitis    venturebeat.com